.jpg)
Nephrogen
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
180 Varick St Fl 6, New York City, New Y...Website
www.nephrogenbiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nephrogen
Nephrogen is a preclinical biotech company focused on developing curative genomic medicines for serious diseases, particularly kidney and pancreatic diseases that affect 1 in 5 Americans. The company utilizes its AI-driven NeFIND platform to engineer novel gene delivery vectors, addressing the significant delivery challenges associated with genomic medicine. Nephrogen aims to improve the longevity and quality of life for millions of Americans by creating effective treatments for these difficult-to-treat conditions. Founded by experts from Stanford and Harvard, the company is committed to advancing the field of genomic medicine through innovative research and technology.Explore more
Nephrogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nephrogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nephrogen recently announced quarterly report
Nephrogen, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Nephrogen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Nephrogen
Product Launch: Get notified when Nephrogen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nephrogen had a recent Job posting/layoffs
Check out if Nephrogen is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Nephrogen has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Nephrogen
Compare insights from companies similar to Nephrogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nephrogen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nephrogen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nephrogen.
Nephrogen Tech Stack
A closer look at the technologies used by Nephrogen
See more technologies
Nephrogen News & Media
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her blood filtered by a machine since her own kidneys could no longer function independently. Two years later, Maxim’s mother received a […]
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nephrogen
Sign Up For FreeTo access detailed company insights
Nephrogen is a preclinical biotech company focused on developing curative genomic medicines for serious diseases, particularly kidney and pancreatic diseases that affect 1 in 5 Americans. The company utilizes its AI-driven NeFIND platform to engineer novel gene delivery vectors, addressing the significant delivery challenges associated with genomic... Read More
